Hoka S, Yamaura K, Takenaka T, Takahashi S
Department of Anesthesiology, Kitasato University School of Medicine, Sagamihara, Kanagawa, Japan.
Anesthesiology. 1998 Dec;89(6):1495-500. doi: 10.1097/00000542-199812000-00028.
Venodilation is thought to be one of the mechanisms underlying propofol-induced hypotension. The purpose of this study is to test two hypotheses: (1) propofol increases systemic vascular capacitance, and (2) the capacitance change produced by propofol is a result of an inhibition of sympathetic vasoconstrictor activity.
In 33 Wistar rats previously anesthetized with urethane and ketamine, vascular capacitance was examined before and after propofol infusion by measuring mean circulatory filling pressure (Pmcf). The Pmcf was measured during a brief period of circulatory arrest produced by inflating an indwelling balloon in the right atrium. Rats were assigned into four groups: an intact group, a sympathetic nervous system (SNS)-block group produced by hexamethonium infusion, a SNS-block + noradrenaline (NA) group, and a hypovolemic group. The Pmcf was measured at a control state and 2 min after a bolus administration of 2, 10, and 20 mg/kg of propofol.
The mean arterial pressure (MAP) was decreased by propofol dose-dependently in intact, hypovolemic, and SNS-block groups, but the decrease in MAP was less in the SNS-block group (-25%) than in the intact (-50%) and hypovolemic (-61%) groups. In the SNS-block + NA group, MAP decreased only at 20 mg/kg of propofol (-18%). The Pmcf decreased in intact and hypovolemic groups in a dose-dependent fashion but was unchanged in the SNS-block and SNS-block + NA groups.
The results have provided two principal findings: (1) propofol decreases Pmcf dose-dependently, and (2) the decrease in Pmcf by propofol is elicited only when the sympathetic nervous system is intact, suggesting that propofol increases systemic vascular capacitance as a result of an inhibition of sympathetic nervous system.
静脉扩张被认为是丙泊酚诱导低血压的潜在机制之一。本研究的目的是验证两个假设:(1)丙泊酚增加全身血管容量;(2)丙泊酚引起的容量变化是交感缩血管活性受抑制的结果。
在33只先前用乌拉坦和氯胺酮麻醉的Wistar大鼠中,通过测量平均循环充盈压(Pmcf)来检测丙泊酚输注前后的血管容量。Pmcf在右心房留置球囊充气导致短暂循环停止期间测量。大鼠被分为四组:完整组、六甲铵输注产生的交感神经系统(SNS)阻断组、SNS阻断+去甲肾上腺素(NA)组和低血容量组。在对照状态下以及推注2、10和20mg/kg丙泊酚后2分钟测量Pmcf。
在完整组、低血容量组和SNS阻断组中,丙泊酚使平均动脉压(MAP)呈剂量依赖性降低,但SNS阻断组中MAP的降低(-25%)小于完整组(-50%)和低血容量组(-61%)。在SNS阻断+NA组中,仅在丙泊酚剂量为20mg/kg时MAP降低(-18%)。完整组和低血容量组中Pmcf呈剂量依赖性降低,但在SNS阻断组和SNS阻断+NA组中未改变。
结果提供了两个主要发现:(1)丙泊酚使Pmcf呈剂量依赖性降低;(2)丙泊酚仅在交感神经系统完整时引起Pmcf降低,提示丙泊酚通过抑制交感神经系统增加全身血管容量。